{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-061939","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2025-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.846677+00:00","generated_at":"2026-05-18T09:07:10.261648+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BiomX publishes Phase 1b/2a BX004 data in Nature Communications; shows 500-fold bacterial reduction","bullets":["BX004 achieved 2.7 log10 (~500-fold) greater bacterial reduction vs placebo in CF patients with chronic P. aeruginosa infections.","No bacterial resistance to BX004 emerged during the trial, addressing a key limitation of antibiotics.","Phase 2b trial of BX004 initiated; topline results expected Q1 2026.","BX004 was safe and well-tolerated with no treatment-related safety events across all patients and dose levels.","Therapeutic phages were detected at infection site up to one week after end of therapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-061939","json":"https://secwatch.observer/filing/0001213900-25-061939.json","markdown":"https://secwatch.observer/filing/0001213900-25-061939.md","text":"https://secwatch.observer/filing/0001213900-25-061939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025061939/0001213900-25-061939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390025061939/ea0248257-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:07:10.261648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}